The largest database of trusted experimental protocols

Promosil c18 column

Manufactured by Agela Technologies
Sourced in China

Promosil C18 column is a type of high-performance liquid chromatography (HPLC) column used for the separation and analysis of various chemical compounds. It is primarily composed of a silica-based stationary phase with chemically bonded C18 alkyl chains, which provides a reversed-phase separation mechanism. The Promosil C18 column is designed to offer consistent performance and reliable results for a wide range of analytical applications.

Automatically generated - may contain errors

5 protocols using promosil c18 column

1

Encapsulation Efficiency of Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The encapsulation efficiency (EE%) of liposomes was carried out by the ultrafiltration method [20 (link)]. Briefly, 500 μL of liposomes suspension was taken into a 0.5 mL centrifugal filter tube (100 kDa, Millipore, Billerica, MA, USA) and centrifuged at 5000× g for 15 min. The supernatant was collected, diluted to 5 mL with methanol and detected by HPLC (Hitachi, Shiga, Japan) at 254 nm. The mobile phase containing methanol and water (70:30 v/v) was pumped through a Promosil C18 column (4.6 × 250 mm, 5 μm, Agela Technologies, Tianjin, China) at a constant flow rate of 0.8 mL/min. The column temperature and injection volume were 40 °C and 10 μL, respectively. The regression equation was y = 2415.09 x + 1989.87 in a range of 10.0–200.0 μg/mL with a good linear relationship (R2 = 0.9997). The EE% and drug loading (DL%) were calculated by the following equations: EE%=WTWFWT×100%,
DL%=WTWFW,
where WT is the total mass of HAS in the liposome suspension (mg); WF is the mass of free HAS in the filtrate (mg); W is the mass of the freeze-dried liposome formulation (mg). All experiments were measured in triplicate.
+ Open protocol
+ Expand
2

Chromatographic Separation of Brimonidine Tartrate

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatographic separation was realized on a Promosil C18 column (4.6 × 250 mm, 5 μm particle size) from Agela Technologies Inc. using a mobile phase consisting of methanol-0.05 M sodium dihydrogen phosphate (35:65, v/v) mixture. The pH of the mixture was adjusted to 2.5 with 0.05 M orthophosphoric acid. The mobile phase was filtered with 0.45 μm Millipore membrane filter and degassed by sonication for 30 min, and then pumped at a flow rate of 1 mL min -1 . The UV detector was set at 220 nm. Brimonidine tartrate was used as an internal standard (IS).
+ Open protocol
+ Expand
3

Purification and Characterization of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents and solvents were purchased commercially and used without further purification. Reaction processes were monitored by thin‐layer chromatography (TLC) and visualized under UV light at 254 and 365 nm, or color reagents. Column chromatography was conducted on silica gel (300–400 mesh) using automatic purification apparatus. 1H NMR and 13C NMR spectra were recorded on Bruker AC400 and Bruker AC600NMR spectrometer respectively in Chloroform‐d or DMSO‐d6 with tetramethylsilane (TMS) as an internal reference. High‐resolution mass spectra were recorded on triple TOF 5600+ MS/MS system (AB Sciex, Concord, Ontario, Canada) in negative or positive ESI mode. The purity of target compounds was determined by high‐performance liquid chromatography with Promosil C18 column from Agela Technologies (4.6 mm × 150 mm, 5 µm particle size). Mobile phase A was double distilled water containing 0.1% trifluoroacetic acid and mobile phase B was methanol containing 0.1% trifluoroacetic acid. Flow rate was 1 mL min−1 using linear gradients as follows: 0–1 min was 40%B, 1–5 min was from 40%B to 95%B, 5–7 min was 95%B, 7–8 min was from 95%B to 40%B, 8–10 min was 40%B. All the biologically tested compounds confirmed at least 95% purity.
+ Open protocol
+ Expand
4

HPLC Chromatographic Separation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatographic separation was performed using a Merck Hitachi HPLC system (Darmstadt, Germany) equipped with L-7100 chromatograph with a Rheodyne injector valve and 20 μL loop, L-7400 UV detector and D-7500 integrator. An NV P-901 digital pH-meter (Consort, Turnhout, Belgium) and a tablet dissolution tester from Abbota Corp., NJ, USA were used. A Promosil C18 column (4.6 × 250 mm, 5 μm particle size) from Agela Technologies Inc., NJ, USA and a Shim-pack CLC C8 column (4.6 × 250 mm, 5 μm particle size) from Shimadzu Corp., Kyoto, Japan were used.
+ Open protocol
+ Expand
5

Quantification of Lornoxicam using HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lornoxicam was quantified using a validated High Pressure Liquid Chromatography (HPLC) method. Schimadzu revers phase-HPLC equipped with LC20D pump and ultraviolet–visible detector (SPD-20A) was used for analysis purpose. Mobile phase consisted of methanol, acetonitrile and phosphate buffer (pH 7.4) at a volume ratio of 40:40:20, respectively. Mobile phase was flowing through a Promosil C18 column (Agela technologies, Tianjin, China) at 1 mL/min flow rate at ambient conditions. The injection volume was 20 µL. The lornoxicam eluted at 2.825 min and a symmetric peak was recorded at 290 nm as depicted in Fig. S1. A calibration curve was plotted using a series of standard solutions of lornoxicam in the concentration range of 1.25–10 µg/mL (Fig. S2), which turns out to be linear (y = 21080x + 5164.9) with R2 value of 0.999. The accuracy was ranged between 99% and 102%, while the precision (CV) was <5% for the assay in the given range of concentrations. The inter- and intra-day variations were also checked.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!